Results 211 to 220 of about 8,603,806 (347)

Co-occurrence of Quinolone Resistance (Qnr) Genes and ESBL (CTX-M) in Uropathogenic Klebsiella pneumoniae and Escherichia coli from Patients in Onitsha, Nigeria

Uchechukwu Glory Mgbedo, Ugochukwu Moses Okezie, Chidimma R. Chukwunwejim, Ijeoma N Ebenebe, Nzube Ekpunobi, E. U. Umeh, Sandra C. Okoye, Lydia Chidinma Okoye, Moses Ikegbunam, Malachy C. Ugwu   +9 more
openalex   +1 more source

Wastewater surveillance of antibiotic resistance and class 1 integron-integrase genes: Potential impact of wastewater characteristics on genes profile [PDF]

Zahra Shamsizadeh, Mahnaz Nikaeen, Farzaneh Mohammadi, Marzieh Farhadkhani, Mehdi Mokhtari, Mohammad Hassan Ehrampoush   +5 more
openalex   +1 more source

Novel IL33 Gene Polymorphisms Associated with Asthma Are Associated with Resistance to Schistosoma Mansoni [PDF]

, 2013
Hironori Masuko, Li Gao, Nicholas Rafaels, Candelaria Vergara, Lili Huang, Monica Campbell, Ingo Ruczinski, Terri H. Beaty, Ricardo Riccio Oliveira, Álvaro A. Cruz, Edgar M. Carvalho, Rasika A. Mathias, Maria Ilma Araújo, Kathleen C. Barnes   +13 more
openalex   +1 more source

Diverse and abundant antibiotic resistance genes in Chinese swine farms

Proceedings of the National Academy of Sciences of the United States of America, 2013
Yong-guan Zhu, T. Johnson, Jianqiang Su, M. Qiao, Guang-xia Guo, Robert D. Stedtfeld, S. Hashsham, J. Tiedje   +7 more
semanticscholar   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Antimicrobial resistance genes in weaned pigs: quantitative abundance and group dynamics assessed by qPCR. [PDF]

Front Vet Sci
Jaleta M, Junker V, Hölzel C, Zentek J, Amon T, Nübel U, Kabelitz T.   +6 more
europepmc   +1 more source

Resistance genes mapped [PDF]

Nature, 2014
openaire   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Evidence for genes controlling resistance to Heligmosomoides bakeri on mouse chromosome 1 [PDF]

, 2014
Harry Noyes, J.B. Githiori, Janette E. Bradley, Stephen J. Kemp, Jerzy M. Behnke   +4 more
openalex   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source